OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services with over 100 beds, continues its collaboration with Cambridge Cognition on electronic Visual Analog Scales (eVAS) for Human Abuse Liability (HAL) clinical trials.
Secondary to the guidance documents released in recent years by the FDA on abuse liability assessments for new chemical entities and abuse deterrent formulations, there has been an increased demand for HAL clinical trials. In response to the guidance documents, Vince & Associates formed a collaboration with Cambridge Cognition, the global leader in touchscreen cognitive assessments for clinical trials, and together these companies have been successfully conducting HAL trials for years.
Dr. Brad Vince, CEO and Medical Director of Vince & Associates, states, “the software platform for cloud-based electronic visual analog scales created by Cambridge Cognition enables Vince & Associates to provide its clients with high quality research data for human abuse liability trials.”
Dr. Nick Kerton, CEO of Cambridge Cognition added, “our collaboration with Vince & Associates Clinical Research continues to enable the provision of scientific expertise through innovative technology to the global biopharmaceutical industry. Through our Cantab Connect software platform we share a collective commitment to excellence in clinical trials that deal with human abuse liability, drug characterization and safety.”
Vince & Associates has been highly successful in conducting abuse liability studies due in large part to their access to an extensive database of recreational drug users for rapid study enrollment. Additionally, the Physician Investigators have been working with both substance dependent volunteers as well as recreational drug users for many years and are experienced in the identification of appropriate study subjects for all types of substance abuse studies, including Human Abuse Liability.
About Vince & Associates Clinical Research
Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for 15 years. The research professionals at Vince & Associates are proud to be recognized in the industry as a “Center of Research Excellence.”
Vince & Associates currently operates a state-of-the-art, multimillion-dollar, 100-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. This early development unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short and long-term clinical trials. From the safety and security of the controlled access unit to the added features of a movie theater and game rooms, no detail has been overlooked.
Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical Research (Kansas, USA) and Algorithme Pharma (Quebec, Canada). Both organizations provide comprehensive early stage clinical services in Phase I/IIa, including the necessary support services in this critical stage of drug development.
Additional background materials pertaining to Vince & Associates Clinical Research are located on the corporate website at www.vinceandassociates.com.